Cargando…
Molecular Pathology of Human Papilloma Virus-Negative Cervical Cancers
SIMPLE SUMMARY: Although cervical cancer is mainly caused by infection with human papillomavirus (HPV), some cervical cancers test negative for HPV. As these HPV-negative cervical cancers are often diagnosed at an advanced stage and have a poor prognosis, it is important to understand their molecula...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699825/ https://www.ncbi.nlm.nih.gov/pubmed/34944973 http://dx.doi.org/10.3390/cancers13246351 |
_version_ | 1784620607225200640 |
---|---|
author | Yoshida, Hiroshi Shiraishi, Kouya Kato, Tomoyasu |
author_facet | Yoshida, Hiroshi Shiraishi, Kouya Kato, Tomoyasu |
author_sort | Yoshida, Hiroshi |
collection | PubMed |
description | SIMPLE SUMMARY: Although cervical cancer is mainly caused by infection with human papillomavirus (HPV), some cervical cancers test negative for HPV. As these HPV-negative cervical cancers are often diagnosed at an advanced stage and have a poor prognosis, it is important to understand their molecular pathology. Here, we provide an overview of the potential causes of false-negative HPV tests, as well as the histology, genetic profile, and pathogenesis of HPV-negative cancers. ABSTRACT: Cervical cancer is the fourth most common cancer in women worldwide and is predominantly caused by infection with human papillomavirus (HPV). However, a small subset of cervical cancers tests negative for HPV, including true HPV-independent cancers and false-negative cases. True HPV-negative cancers appear to be more prevalent in certain pathological adenocarcinoma subtypes, such as gastric- and clear-cell-type adenocarcinomas. Moreover, HPV-negative cervical cancers have proven to be a biologically distinct tumor subset that follows a different pathogenetic pathway to HPV-associated cervical cancers. HPV-negative cervical cancers are often diagnosed at an advanced stage with a poor prognosis and are expected to persist in the post-HPV vaccination era; therefore, it is important to understand HPV-negative cancers. In this review, we provide a concise overview of the molecular pathology of HPV-negative cervical cancers, with a focus on their definitions, the potential causes of false-negative HPV tests, and the histology, genetic profiles, and pathogenesis of HPV-negative cancers. |
format | Online Article Text |
id | pubmed-8699825 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-86998252021-12-24 Molecular Pathology of Human Papilloma Virus-Negative Cervical Cancers Yoshida, Hiroshi Shiraishi, Kouya Kato, Tomoyasu Cancers (Basel) Review SIMPLE SUMMARY: Although cervical cancer is mainly caused by infection with human papillomavirus (HPV), some cervical cancers test negative for HPV. As these HPV-negative cervical cancers are often diagnosed at an advanced stage and have a poor prognosis, it is important to understand their molecular pathology. Here, we provide an overview of the potential causes of false-negative HPV tests, as well as the histology, genetic profile, and pathogenesis of HPV-negative cancers. ABSTRACT: Cervical cancer is the fourth most common cancer in women worldwide and is predominantly caused by infection with human papillomavirus (HPV). However, a small subset of cervical cancers tests negative for HPV, including true HPV-independent cancers and false-negative cases. True HPV-negative cancers appear to be more prevalent in certain pathological adenocarcinoma subtypes, such as gastric- and clear-cell-type adenocarcinomas. Moreover, HPV-negative cervical cancers have proven to be a biologically distinct tumor subset that follows a different pathogenetic pathway to HPV-associated cervical cancers. HPV-negative cervical cancers are often diagnosed at an advanced stage with a poor prognosis and are expected to persist in the post-HPV vaccination era; therefore, it is important to understand HPV-negative cancers. In this review, we provide a concise overview of the molecular pathology of HPV-negative cervical cancers, with a focus on their definitions, the potential causes of false-negative HPV tests, and the histology, genetic profiles, and pathogenesis of HPV-negative cancers. MDPI 2021-12-17 /pmc/articles/PMC8699825/ /pubmed/34944973 http://dx.doi.org/10.3390/cancers13246351 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Yoshida, Hiroshi Shiraishi, Kouya Kato, Tomoyasu Molecular Pathology of Human Papilloma Virus-Negative Cervical Cancers |
title | Molecular Pathology of Human Papilloma Virus-Negative Cervical Cancers |
title_full | Molecular Pathology of Human Papilloma Virus-Negative Cervical Cancers |
title_fullStr | Molecular Pathology of Human Papilloma Virus-Negative Cervical Cancers |
title_full_unstemmed | Molecular Pathology of Human Papilloma Virus-Negative Cervical Cancers |
title_short | Molecular Pathology of Human Papilloma Virus-Negative Cervical Cancers |
title_sort | molecular pathology of human papilloma virus-negative cervical cancers |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699825/ https://www.ncbi.nlm.nih.gov/pubmed/34944973 http://dx.doi.org/10.3390/cancers13246351 |
work_keys_str_mv | AT yoshidahiroshi molecularpathologyofhumanpapillomavirusnegativecervicalcancers AT shiraishikouya molecularpathologyofhumanpapillomavirusnegativecervicalcancers AT katotomoyasu molecularpathologyofhumanpapillomavirusnegativecervicalcancers |